TheEdgeResearch
Home / Stocks / SHPMF

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

OTC Healthcare Medical - Distribution
$1.46 ▲ +0.00%
Market Cap
$8.46B
Sector
Healthcare
Industry
Medical - Distribution
Beta
0.16
52-Wk Range
1.46-15.7
CEO
Qiuhua Yang
Country
CN
Currency
USD

Shanghai Pharmaceuticals Holding Co., Ltd operates in the Medical - Distribution industry of the Healthcare sector, headquartered in Shanghai, SHA, CN. The stock last traded at $1.46, up 0.00% on the session, giving a market capitalisation of $8.46B. On trailing twelve-month figures it carries a trailing P/E of 11.80, a net margin of 1.8%. Its beta of 0.16 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
11.80
Price / Sales
0.16
Price / Book
0.77
EV / EBITDA
6.18
Gross margin
10.6%
Operating margin
2.9%
Net margin
1.8%
Return on equity
—
Debt / equity
0.75
Current ratio
1.35
Dividend yield
3.5%
Payout ratio
65.5%
Company profile
Exchange
Other OTC
Employees
49,608
IPO date
2013-01-22
Headquarters
Shanghai, SHA, CN
About Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.

More research on SHPMF
SHPMF technical analysis SHPMF TheEdge Score Compare against peers
Open full interactive analysis & DCF →